PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-164

  1. 685 Posts.
    lightbulb Created with Sketch. 130
    we do have proof of not just pain reduction from the phase 2b trials. there is proof of remediation in bone marrow lesions also. You cant get that in placebo-controlled trial.
    Last edited by mitchy: 31/07/20
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.